ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Prognostic microRNA signature for estimating survival in patients with hepatocellular carcinoma

Sathipati, Srinivasulu Yerukala*; Aimalla, Nikhila; Tsai, Ming-Ju; Carter, Tonia; Jeong, Sohyun; Wen, Zhi; Shukla, Sanjay K.; Sharma, Rohit; Ho, Shinn-Ying
Carcinogenesis2023-12-2DOI: 10.1093/carcin/bgad062
4被引6阅读
引用收藏
分享

摘要

Objective Hepatocellular carcinoma (HCC) is one of the leading cancer types with increasing annual incidence and high mortality in the USA. MicroRNAs (miRNAs) have emerged as valuable prognostic indicators in cancer patients. To identify a miRNA signature predictive of survival in patients with HCC, we developed a machine learning-based HCC survival estimation method, HCCse, using the miRNA expression profiles of 122 patients with HCC.Methods The HCCse method was designed using an optimal feature selection algorithm incorporated with support vector regression.Results HCCse identified a robust miRNA signature consisting of 32 miRNAs and obtained a mean correlation coefficient (R) and mean absolute error (MAE) of 0.87 +/- 0.02 and 0.73 years between the actual and estimated survival times of patients with HCC; and the jackknife test achieved an R and MAE of 0.73 and 0.97 years between actual and estimated survival times, respectively. The identified signature has seven prognostic miRNAs (hsa-miR-146a-3p, hsa-miR-200a-3p, hsa-miR-652-3p, hsa-miR-34a-3p, hsa-miR-132-5p, hsa-miR-1301-3p and hsa-miR-374b-3p) and four diagnostic miRNAs (hsa-miR-1301-3p, hsa-miR-17-5p, hsa-miR-34a-3p and hsa-miR-200a-3p). Notably, three of these miRNAs, hsa-miR-200a-3p, hsa-miR-1301-3p and hsa-miR-17-5p, also displayed association with tumor stage, further emphasizing their clinical relevance. Furthermore, we performed pathway enrichment analysis and found that the target genes of the identified miRNA signature were significantly enriched in the hepatitis B pathway, suggesting its potential involvement in HCC pathogenesis.Conclusions Our study developed HCCse, a machine learning-based method, to predict survival in HCC patients using miRNA expression profiles. We identified a robust miRNA signature of 32 miRNAs with prognostic and diagnostic value, highlighting their clinical relevance in HCC management and potential involvement in HCC pathogenesis. Graphical Abstract

学科与关键词

关键词
ARTIFICIAL-INTELLIGENCECELL-PROLIFERATIONPOOR-PROGNOSISUP-REGULATIONTUMOR-GROWTHDIAGNOSISEXPRESSIONLIVERMIGRATIONTARGETS
相关
加载中…
  • Immune-related microRNA signature for predicting prognosis and the immune microenvironment in hepatocellular carcinoma.
    Li, Yue; He, Xiaoqin; Zhang, Xiaoyu; Xu, Yangtao; Wu, Yaogui*; Xu, Ximing*Life Sciences, 2021, 265: 118799.
  • The prognostic role of an optimal machine learning model based on clinical available indicators in HCC patients
    Lou, Xiaoying; Ma, Shaohui; Ma, Mingyuan; Wu, Yue; Xuan, Chengmei; Sun, Yan; Liang, Yue; Wang, Zongdan; Gao, Hongjun*Frontiers in Medicine, 2024, 11: 1431578.被引 1
  • A Comprehensive Prognostic and Immunological Analysis of a New Three-Gene Signature in Hepatocellular Carcinoma
    Liu, Jun; Lu, Jianjun; Li, Wenli*2021, 2021: 5546032.被引 8
查看全部 →

发表信息

论文状态
公开发表
期刊
Carcinogenesis
发表日期
2023-12-02
卷期
第 44 卷, 第 8-9 期
页码
650-661
DOI
10.1093/carcin/bgad062
语言
ENGLISH
成果收录
SCIE
资助标注
Marshfield Clinic Research Institute Independent Investigator funding; Weber Endowment

作者

  • S

    Sathipati, Srinivasulu Yerukala (通讯) (第一作者)

  • A

    Aimalla, Nikhila

查看全部 9 位作者收起作者
  • T

    Tsai, Ming-Ju

  • C

    Carter, Tonia

  • J

    Jeong, Sohyun

  • W

    Wen, Zhi

  • S

    Shukla, Sanjay K.

  • S

    Sharma, Rohit

  • H

    Ho, Shinn-Ying

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417